Piyasa Haberleri

En güncel finans ve ekonomi haberlerini, piyasa gelişmelerini, raporları ve analizleri PipVero’da takip edin.

Kaynak: 24/7 Wall Street Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Joby Aviation Climbs 9% on Raised Guidance as Archer Aviation, EHang Sit Out the eVTOL Rally

Joby Aviation Climbs 9% on Raised Guidance as Archer Aviation, EHang Sit Out the eVTOL Rally

Joby Aviation (NYSE:JOBY | JOBY Price Prediction) stock is rallying Thursday, with shares up 9% to $8.47 by midday after the electric air taxi maker raised its full-year 2026 revenue outlook alongside Joby's Q2 FY2026 report released after Wednesday's close.

İlgili Semboller 1
EH EH
Kaynak: 24/7 Wall Street
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Fresnillo: The Production Decline Is Masking A Balance Sheet Reinvention

Fresnillo: The Production Decline Is Masking A Balance Sheet Reinvention

Fresnillo is undervalued, trading at discounted P/E and EV/EBITDA multiples despite strong financials and a robust resource base. I see the market is overly focused on near-term production declines, missing Fresnillo's strategic moves to extend asset duration and diversify geographically. Recent Probe Gold acquisition adds 10 million ounces of gold resources, reduces Mexico's concentration risk, and extends portfolio life without balance sheet strain.

İlgili Semboller 1
FNLPF FNLPF
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Earnings Estimates Rising for Life Time Group Holdings (LTH): Will It Gain?

Earnings Estimates Rising for Life Time Group Holdings (LTH): Will It Gain?

Life Time Group Holdings, Inc. (LTH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

İlgili Semboller 1
LTH LTH
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?

Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?

Strata Critical Medical, Inc. (SRTA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

İlgili Semboller 1
SRTA SRTA
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Valero Energy Stock: Buy at a Premium or Wait for a Better Entry Point?

Valero Energy Stock: Buy at a Premium or Wait for a Better Entry Point?

Valero Energy Corporation VLO is currently considered expensive on a relative basis, with the stock trading at a 6.44x trailing 12-month Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization (EV/EBITDA), which is a premium compared with the broader industry average of 5.77x.

İlgili Semboller 1
VLO VLO
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
Official Partner ITBFX Start Trading
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
How Quanta's Raised 2026 Outlook Could Reshape Its Growth Story Ahead

How Quanta's Raised 2026 Outlook Could Reshape Its Growth Story Ahead

Quanta Services, Inc. PWR raised its full-year revenue, earnings, adjusted EBITDA and free-cash-flow outlook after second-quarter results exceeded expectations. The revision changes the scale of the 2026 growth story.

İlgili Semboller 1
QNTA QNTA
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Zacks Investment Research Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?

ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?

ABBV falls after cutting its 2026 EPS outlook to reflect the Apogee deal, despite strong Q2 results, higher revenue guidance and growth from key medicines.

İlgili Semboller 1
ABBV ABBV
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap